About Us

Vision & Mission


To improve the healthcare journey and outcomes for individuals with complex, chronic diseases through innovative and actionable precision medicine testing solutions for immune-mediated inflammatory diseases.


We empower healthcare specialists with the ability to accelerate the achievement of sustained disease remission and disease control. Our precision-guided testing services enable clinicians to achieve improved outcomes, while supporting payer objectives of cost-effective care.


Mike Walther

Mike Walther, President and Board member. Mike has 30 years of expertise leading start up to established therapeutics, diagnostics and medical device businesses. Prior to joining…

Read More

Thierry Dervieux, PharmD, PhD

Thierry Dervieux, PharmD, PhD, Chief Scientific Officer, was most recently Chief Scientific Officer at Exagen Diagnostics, where he spent a decade building the Avise® portfolio of testing solutions…

Read More

Patricia Vasquez

Patricia Vasquez, Senior Vice President, Commercial and Corporate Development, most recently served as Vice President, Global Marketing, Business Development…

Read More

Brian Littlefied

Brian Littlefield, Senior Vice President of Information Services. Previously, Brian served at Exagen Diagnostics, where he established the IS function, and developed…

Read More

Lei Lu

Lei Lu, Senior Vice President, Finance and Accounting, most recently served as Executive Vice President, Finance for HUYABIO, where he was responsible for leading…

Read More

Claudia Ibarra

Claudia Ibarra, Senior Vice President, Technical Operations, was most recently Chief Operating Officer at DermTech, where she led a dynamic team of scientists, customer…

Read More

Michael Walsh

Michael Walsh, Chairman, most recently served as a Board Member for Lineagen, which provided specialized genetic testing for children with…

Read More

Scott Glenn

Scott Glenn is Managing Partner of Windamere Venture Partners and Chairman of ReBalance Health. He founded and sold, or took public…

Read More

Mike Walther

Mike Walther, President and Board member. Mike has 30 years of expertise leading start up to established therapeutics, diagnostics and medical device businesses…

Read More

Rolf Benirschke

Rolf Benirschke is CEO of Legacy Health Strategies, a patient engagement company, and founder of The Grateful Patient Project. As a former NFL placekicker…

Read More

James Laur

James Laur is Vice President, Intellectual Property at Cedars Sinai, leading the Technology Ventures Office. He also serves as Managing Director of…

Read More

Martin Hendrix

Martin Hendrix serves as the Global Head of Business Development and M&A for Nestlé Health Science, a division of Nestlé S.A. He is responsible for…

Read More
Scientific Advisors

Dermot McGovern, MD, PhD

Dr. McGovern is a gastroenterologist and preeminent geneticist in the IBD field. Dr. McGovern completed his GI fellowship and obtained a PhD in complex disease genetics at the University of Oxford, England before moving to Cedars-Sinai …

Read More

Adam Cheifetz, MD

Adam S. Cheifetz is the Director of the Center for Inflammatory Bowel Disease and Medical Director of Infusion Services at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. He is also Director of the Harvard Medical School Gastroenterology…

Read More

Marla C Dubinsky, MD

Marla C Dubinsky is a Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her pediatric residency at…

Read More

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE

Bincy P. Abraham is the Distinguished Professor and Director of the Fondren Inflammatory Bowel Disease Program at the Underwood Digestive Diseases Center of Houston Methodist Hospital…

Read More